The CEO of Bruker Corp (NASDAQ: BRKR) is Buying SharesBy Carrie Williams
Following Frank Laukien’s last BRKR Buy transaction on December 15, 2016, the stock climbed by 2.3%. In addition to Frank Laukien, 3 other BRKR executives reported Buy trades in the last month.
The company has a one year high of $29.85 and a one year low of $19.59. BRKR’s market cap is $3.81B and the company has a P/E ratio of 25.09. Currently, Bruker Corp has an average volume of 441.8K.
17 different firms, including Avondale and Barclays, currently also have a Buy rating on the stock. Based on 6 analyst ratings, the analyst consensus is Hold with an average price target of $25.00, reflecting a -4.4% downside.
In the last 30 days, insiders have sold $30.48K worth of BRKR shares and purchased $178K worth of BRKR shares. The insider sentiment on Bruker Corp has been positive according to 37 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Bruker Corp. designs and manufactures scientific instruments and analytical and diagnostic solutions that enable its customers to explore life and materials at microscopic, molecular and cellular levels. Its technology platforms include magnetic resonance technologies, mass spectrometry technologies, gas and liquid chromatography triple quadrupole mass spectrometry technologies, X-ray technologies, spark-optical emission spectroscopy, atomic force microscopy, stylus and optical metrology technology, fluorescence optical microscopy and infrared and raman molecular spectroscopy technologies. The company operates its business through two segments: Bruker Scientific Instruments and Bruker Energy and Supercon Technologies. The Bruker Scientific Instruments are organized into three operating segments: the Bruker BioSpin Group, the Bruker CALID Group and the Bruker Nano Group. Bruker was founded by Günther Laukien and Emil Bruker in 1960 and is headquartered in Billerica, MA.